| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 8 |
| 1 | CISPLATIN | 7 |
| 2 | FLUOROURACIL | 7 |
| 3 | FLUOROURACIL CREAM, 0.5% | 7 |
| 4 | NORETHINDRONE | 5 |
| 5 | CARBOPLATIN | 4 |
| 6 | PACLITAXEL | 4 |
| 7 | PROPRANOLOL HYDROCHLORIDE | 4 |
| 8 | DOXAZOSIN | 3 |
| 9 | DOXAZOSIN MESYLATE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NORETHINDRONE | 5 | 0.0009 |
| 1 | NICARDIPINE | 3 | 0.0007 |
| 2 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 3 | NALDEMEDINE | 1 | 0.0006 |
| 4 | TESTOSTERONE CYPIONATE | 3 | 0.0003 |
| 5 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 6 | ERIBULIN MESYLATE | 1 | 0.0003 |
| 7 | CABERGOLINE | 1 | 0.0002 |
| 8 | CALCIUM ACETATE | 1 | 0.0002 |
| 9 | AFATINIB | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 11 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 7 |
| 3 | Microtubule Inhibitor [EPC] | 5 |
| 4 | Progestin [EPC] | 5 |
| 5 | Insulin Analog [EPC] | 4 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 3 |
| 7 | Corticosteroid [EPC] | 3 |
| 8 | Kinase Inhibitor [EPC] | 3 |
| 9 | Alkylating Drug [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 1 | Progesterone [EPC] | 2 | 0.0001 |
| 2 | Androgen [EPC] | 2 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Progestin [EPC] | 5 | 0.0000 |